KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Buildings (2017 - 2025)

Repligen (RGEN) has disclosed Buildings for 9 consecutive years, with $763000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Buildings rose 13.04% to $763000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $763000.0, a 13.04% increase, with the full-year FY2025 number at $763000.0, up 13.04% from a year prior.
  • Buildings was $763000.0 for Q4 2025 at Repligen, roughly flat from $763000.0 in the prior quarter.
  • In the past five years, Buildings ranged from a high of $1.7 million in Q4 2023 to a low of $637000.0 in Q3 2022.
  • A 5-year average of $966750.0 and a median of $763000.0 in 2025 define the central range for Buildings.
  • Peak YoY movement for Buildings: skyrocketed 156.99% in 2023, then tumbled 59.51% in 2024.
  • Repligen's Buildings stood at $764000.0 in 2021, then soared by 109.29% to $1.6 million in 2022, then rose by 4.25% to $1.7 million in 2023, then crashed by 59.51% to $675000.0 in 2024, then grew by 13.04% to $763000.0 in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Buildings are $763000.0 (Q4 2025), $763000.0 (Q3 2025), and $763000.0 (Q2 2025).